HAL (France)open access
Hydroxychloroquine does not affect endotheliopathy or coagulopathy biomarkers in COVID-19: longitudinal results from the DisCoVeRy randomized trial
1, COVID-19, Angiopoiétin-2, Hydroxychloroquine, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 176767
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.